| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.921 | 0.003 | 0.921 | Epidermal growth factor receptor kinase inhibitor | 0.899 0.003 DBMET02190 | ||
| 0.914 | 0.003 | 0.914 | Epidermal growth factor antagonist | 0.874 0.003 DBMET02190 | ||
| 0.912 | 0.003 | 0.912 | ErbB-4 antagonist | 0.87 0.003 DBMET02190 | ||
| 0.873 | 0.004 | 0.873 | Growth factor antagonist | 0.808 0.005 DBMET02190 | ||
| 0.803 | 0.003 | 0.803 | ErbB-2 antagonist | 0.747 0.003 DBMET02190 | ||
| 0.767 | 0.003 | 0.767 | ErbB-1 antagonist | 0.749 0.003 DBMET02190 | ||
| 0.598 | 0.021 | 0.598 | MAP kinase 1 inhibitor | 0.542 0.038 DBMET02190 | ||
| 0.46 | 0.003 | 0.46 | EphB4 antagonist | 0.298 0.004 DBMET02190 | ||
| 0.441 | 0.005 | 0.441 | Ephrin antagonist | 0.412 0.005 DBMET02190 | ||
| 0.442 | 0.023 | 0.442 | Tyrosine kinase inhibitor | 0.388 0.029 DBMET02190 | ||
| 0.442 | 0.042 | 0.442 | Angiogenesis inhibitor | 0.394 0.055 DBMET02190 | ||
| 0.329 | 0.019 | 0.329 | Vascular endothelial growth factor antagonist | 0.271 0.025 DBMET02190 | ||
| 0.312 | 0.004 | 0.312 | ErbB-3 antagonist | 0.272 0.004 DBMET02190 | ||
| 0.322 | 0.018 | 0.322 | Vascular endothelial growth factor 2 antagonist | 0.259 0.025 DBMET02190 | ||
| 0.324 | 0.024 | 0.324 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.302 0.029 DBMET02190 | ||
| 0.304 | 0.004 | 0.304 | EphA2 antagonist | 0.294 0.004 DBMET02190 | ||
| 0.294 | 0.027 | 0.294 | Src kinase inhibitor | 0.28 0.029 DBMET02190 | ||
| 0.287 | 0.021 | 0.287 | Vascular endothelial growth factor 3 antagonist | 0.234 0.031 DBMET02190 | ||
| 0.252 | 0.025 | 0.255 | c-Src kinase inhibitor | 0.255 0.024 DBMET02190 | DBMET02190 | |
| 0.261 | 0.051 | 0.261 | EphB2 antagonist | 0.251 0.056 DBMET02190 | ||
| 0.219 | 0.014 | 0.219 | MAP kinase kinase kinase inhibitor | 0.214 0.015 DBMET02190 | ||
| 0.252 | 0.06 | 0.252 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.229 0.072 DBMET02190 | ||
| 0.225 | 0.037 | 0.225 | Protein-tyrosine kinase Lyn inhibitor | 0.192 0.049 DBMET02190 | ||
| 0.204 | 0.028 | 0.204 | MAP kinase kinase 5 inhibitor | 0.199 0.034 DBMET02190 | ||
| 0.199 | 0.024 | 0.199 | MAP kinase 3 inhibitor | 0.188 0.03 DBMET02190 | ||
| 0.198 | 0.027 | 0.198 | Vascular endothelial growth factor 1 antagonist | 0.168 0.035 DBMET02190 | ||
| 0.202 | 0.04 | 0.202 | Lck kinase inhibitor | 0.178 0.05 DBMET02190 | ||
| 0.194 | 0.036 | 0.196 | Cyclin-dependent kinase 7 inhibitor | 0.196 0.035 DBMET02190 | DBMET02190 | |
| 0.173 | 0.016 | 0.173 | Insulin growth factor antagonist | 0.11 0.04 DBMET02190 | ||
| 0.176 | 0.02 | 0.176 | Insulin receptor antagonist | 0.098 0.065 DBMET02190 | ||
| 0.168 | 0.015 | 0.168 | Insulin like growth factor 1 antagonist | 0.094 0.046 DBMET02190 | ||
| 0.18 | 0.029 | 0.18 | Platelet activating factor beta antagonist | 0.126 0.047 DBMET02190 | ||
| 0.176 | 0.033 | 0.176 | Platelet activating factor antagonist | 0.116 0.066 DBMET02190 | ||
| 0.141 | 0.012 | 0.141 | Fibroblast growth factor 2 antagonist | 0.064 0.047 DBMET02190 | ||
| 0.151 | 0.03 | 0.151 | Platelet activating factor alpha antagonist | 0.107 0.054 DBMET02190 | ||
| 0.2 | 0.079 | 0.2 | Clk dual-specificity kinase inhibitor | 0.173 0.096 DBMET02190 | ||
| 0.166 | 0.053 | 0.173 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.173 0.05 DBMET02190 | DBMET02190 | |
| 0.166 | 0.054 | 0.166 | RET inhibitor | 0.15 0.061 DBMET02190 | ||
| 0.195 | 0.085 | 0.195 | Platelet aggregation inhibitor | 0.152 0.126 DBMET02190 | ||
| 0.162 | 0.061 | 0.162 | CDC-like kinase 1 inhibitor | 0.133 0.083 DBMET02190 | ||
| 0.179 | 0.079 | 0.179 | CDC-like kinase 4 inhibitor | 0.156 0.096 DBMET02190 | ||
| 0.105 | 0.014 | 0.105 | Bruton tyrosine kinase inhibitor | 0.101 0.014 DBMET02190 | ||
| 0.102 | 0.013 | 0.102 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.139 | 0.058 | 0.175 | MAP kinase kinase inhibitor | 0.175 0.039 DBMET02190 | DBMET02190 | |
| 0.161 | 0.087 | 0.161 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.149 0.096 DBMET02190 | ||
| 0.12 | 0.048 | 0.12 | Multidrug resistance-associated protein 1 inhibitor | 0.114 0.055 DBMET02190 | ||
| 0.17 | 0.104 | 0.192 | MAP kinase kinase 2 inhibitor | 0.192 0.087 DBMET02190 | DBMET02190 | |
| 0.125 | 0.06 | 0.125 | Aurora-B kinase inhibitor | 0.095 0.088 DBMET02190 | ||
| 0.126 | 0.063 | 0.126 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.119 0.07 DBMET02190 | ||
| 0.126 | 0.063 | 0.126 | Abl kinase inhibitor | 0.118 0.07 DBMET02190 | ||
| 0.089 | 0.029 | 0.089 | Raf kinase C inhibitor | 0.088 0.029 DBMET02190 | ||
| 0.109 | 0.05 | 0.109 | Fibroblast growth factor 1 antagonist | |||
| 0.133 | 0.074 | 0.133 | Death-associated protein kinase 1 inhibitor | 0.131 0.079 DBMET02190 | ||
| 0.093 | 0.039 | 0.093 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.09 0.042 DBMET02190 | ||
| 0.132 | 0.079 | 0.135 | Aurora-C kinase inhibitor | 0.135 0.074 DBMET02190 | DBMET02190 | |
| 0.084 | 0.032 | 0.084 | MAP kinase 7 inhibitor | |||
| 0.181 | 0.13 | 0.19 | MAP-kinase-activated kinase 5 inhibitor | 0.19 0.116 DBMET02190 | DBMET02190 | |
| 0.101 | 0.055 | 0.11 | MAP kinase kinase 1 inhibitor | 0.11 0.045 DBMET02190 | DBMET02190 | |
| 0.09 | 0.048 | 0.09 | ALK inhibitor | |||
| 0.114 | 0.072 | 0.114 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.059 | 0.017 | 0.059 | CC chemokine 4 receptor antagonist | |||
| 0.084 | 0.044 | 0.097 | Vanilloid antagonist | 0.097 0.037 DBMET02190 | DBMET02190 | |
| 0.068 | 0.029 | 0.068 | Fibroblast growth factor 4 antagonist | |||
| 0.077 | 0.039 | 0.077 | ZAP-70 protein tyrosine kinase inhibitor | 0.062 0.059 DBMET02190 | ||
| 0.094 | 0.06 | 0.094 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.075 | 0.048 | 0.075 | Janus tyrosine kinase 3 inhibitor | 0.075 0.048 DBMET02190 | ||
| 0.264 | 0.236 | 0.264 | Caspase 9 stimulant | |||
| 0.171 | 0.144 | 0.171 | DNA damaging | |||
| 0.124 | 0.101 | 0.124 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.12 0.107 DBMET02190 | ||
| 0.082 | 0.06 | 0.082 | T cell inhibitor | |||
| 0.093 | 0.072 | 0.093 | Aurora-A kinase inhibitor | |||
| 0.146 | 0.125 | 0.146 | Antimitotic | |||
| 0.059 | 0.04 | 0.059 | CDK9/cyclin T1 inhibitor | 0.055 0.046 DBMET02190 | ||
| 0.079 | 0.06 | 0.079 | TIE antagonist | |||
| 0.078 | 0.059 | 0.078 | TIE-2 antagonist | |||
| 0.05 | 0.032 | 0.05 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.078 | 0.062 | 0.078 | Phosphodiesterase XI inhibitor | |||
| 0.078 | 0.062 | 0.078 | Phosphodiesterase 11A inhibitor | |||
| 0.085 | 0.071 | 0.085 | Polo-like kinase-1 inhibitor | |||
| 0.063 | 0.05 | 0.071 | Vanilloid 1 antagonist | 0.071 0.043 DBMET02190 | DBMET02190 | |
| 0.083 | 0.072 | 0.159 | Potassium channel (Ca-activated) activator | 0.159 0.025 DBMET02190 | DBMET02190 | |
| 0.141 | 0.13 | 0.155 | Death-associated protein kinase 2 inhibitor | 0.155 0.095 DBMET02190 | DBMET02190 | |
| 0.068 | 0.058 | 0.068 | MAP3K7 inhibitor | |||
| 0.074 | 0.064 | 0.074 | Platelet growth factor antagonist | |||
| 0.087 | 0.079 | 0.096 | Cyclin-dependent kinase 9 inhibitor | 0.096 0.067 DBMET02190 | DBMET02190 | |
| 0.076 | 0.068 | 0.076 | AXL receptor tyrosine kinase inhibitor | |||
| 0.08 | 0.072 | 0.08 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.077 0.075 DBMET02190 | ||
| 0.091 | 0.084 | 0.091 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.145 | 0.138 | 0.145 | Focal adhesion kinase 2 inhibitor | |||
| 0.078 | 0.073 | 0.078 | Transforming growth factor beta 3 antagonist | |||
| 0.063 | 0.062 | 0.063 | Raf kinase inhibitor | |||
| 0.026 | 0.028 | 0.028 | MAP3K8 inhibitor | 0.028 0.022 DBMET02190 | DBMET02190 | |
| 0.098 | 0.101 | 0.171 | Interleukin 8 antagonist | 0.171 0.023 DBMET02190 | DBMET02190 | |
| 0.093 | 0.096 | 0.097 | CDC-like kinase 3 inhibitor | 0.097 0.087 DBMET02190 | DBMET02190 | |
| 0.06 | 0.139 | 0.09 | Protein kinase (CK2) alpha inhibitor | 0.09 0.087 DBMET02190 | DBMET02190 | |
| 0.04 | 0.16 | 0.086 | Protein kinase (CK2) inhibitor | 0.086 0.077 DBMET02190 | DBMET02190 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |